The stock has a 36-month beta value of -0.21.
The public float for KLTO is 16.49M, and at present, short sellers hold a 0.64% of that float. On January 15, 2025, the average trading volume of KLTO was 958.08K shares.
KLTO) stock’s latest price update
Klotho Neurosciences Inc (NASDAQ: KLTO)’s stock price has gone decline by -10.34 in comparison to its previous close of 0.48, however, the company has experienced a -19.94% decrease in its stock price over the last five trading days. globenewswire.com reported 2025-01-08 that NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) — Klotho Neurosciences, Inc. (NASDAQ: KLTO), a specialty biotechnology company focused on developing cell and gene therapies for amyotrophic lateral sclerosis (ALS), Alzheimer’s, and Parkinson’s disease, announces that it will present at Biotech Showcase 2025, an event expected to include over 3,200 healthcare professionals with more than 1,200 investors. The event will be held at the Hilton Hotel in Union Square, San Francisco during the J.P.
KLTO’s Market Performance
Klotho Neurosciences Inc (KLTO) has seen a -19.94% fall in stock performance for the week, with a -9.47% decline in the past month and a -17.15% plunge in the past quarter. The volatility ratio for the week is 11.68%, and the volatility levels for the past 30 days are at 16.89% for KLTO. The simple moving average for the past 20 days is -10.91% for KLTO’s stock, with a -84.52% simple moving average for the past 200 days.
KLTO Trading at 0.01% from the 50-Day Moving Average
After a stumble in the market that brought KLTO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -96.72% of loss for the given period.
Volatility was left at 16.89%, however, over the last 30 days, the volatility rate increased by 11.68%, as shares sank -2.54% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -15.67% lower at present.
During the last 5 trading sessions, KLTO fell by -19.94%, which changed the moving average for the period of 200-days by -95.82% in comparison to the 20-day moving average, which settled at $0.4826. In addition, Klotho Neurosciences Inc saw -11.34% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at KLTO starting from CHARDAN CAPITAL MARKETS LLC, who sale 180,000 shares at the price of $2.05 back on Jul 02 ’24. After this action, CHARDAN CAPITAL MARKETS LLC now owns 1,284,364 shares of Klotho Neurosciences Inc, valued at $368,442 using the latest closing price.
CHARDAN CAPITAL MARKETS LLC, the 10% Owner of Klotho Neurosciences Inc, sale 115,136 shares at $2.06 during a trade that took place back on Jul 01 ’24, which means that CHARDAN CAPITAL MARKETS LLC is holding 1,464,364 shares at $237,618 based on the most recent closing price.
Stock Fundamentals for KLTO
Equity return is now at value -13.19, with -11.39 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 0.16.
Conclusion
To sum up, Klotho Neurosciences Inc (KLTO) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
